相关产品推荐更多 >

Sigma货号AB144P抗胆碱乙酰基转移酶抗体13611631389上海睿安生物
¥5016.79
Sigma-Aldrich-Millipore货号05-474抗-GABA A受体β2/3抗体19121878899上海睿安生物Merck-Roche-Millipore-Sigma官方正式授权代理商
¥4586.93
Invitrogen货号A11012现货Goat anti-Rabbit IgG(H+L) Cross-Adsorbed Secondary Antibody,Alexa Fluor™ 594现货19121878899上海睿安生物
¥3325.01
Sigma货号06-866抗乙酰组蛋白H4抗体13611631389上海睿安生物
¥7701.24
Roche_11112589001封闭剂Blocking Reagent上海睿安13611631389
¥1007.85
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 英文名:
SOCS3 Antibody
- 保质期:
1年
- 保存条件:
-20°C
- 库存:
100⁺支
- 供应商:
上海睿安生物19121878899
- 规格:
100μl/支
CST货号2923现货SOCS3 Antibody上海睿安生物19121878899
Source / Purification
Background
Low levels of SOCS3 are observed in lung, spleen and thymus, and like other SOCS family members levels its expression is rapidly induced by a number of factors including interleukins, EPO, IFN-γ, CSF and TNF-α (4). SOCS3 uses its SH2 domain to bind activated Jaks and their cognate receptors to provide negative feedback inhibition. In addition to the initially described inducers of SOCS3 expression, subsequent studies have described SOCS3-mediated negative feedback inhibition for leptin (5), GH (6), chemokine receptors (7), insulin (8) and certain pathogens (9,10). SOCS3 deletion results in embryonic lethality with placental insufficiency (11). SOCS3 signaling has been linked pathologically to allergic responses (12), inflammatory disease (13), endotoxic shock (14), wound repair (15), and obesity (16,17).
- Alexander, W.S. et al. (1999) J Leukoc Biol 66, 588-92.
- Chen, X.P. et al. (2000) Immunity 13, 287-90.
- Hilton, D.J. et al. (1998) Proc Natl Acad Sci USA 95, 114-9.
- Starr, R. et al. (1997) Nature 387, 917-21.
- Bjørbaek, C. et al. (1998) Mol Cell 1, 619-25.
- Adams, T.E. et al. (1998) J Biol Chem 273, 1285-7.
- Soriano, S.F. et al. (2002) J Exp Med 196, 311-21.
- Emanuelli, B. et al. (2000) J Biol Chem 275, 15985-91.
- Stoiber, D. et al. (1999) J Immunol 163, 2640-7.
- Stoiber, D. et al. (2001) J Immunol 166, 466-72.
- Roberts, A.W. et al. (2001) Proc Natl Acad Sci USA 98, 9324-9.
- Seki, Y. et al. (2003) Nat Med 9, 1047-54.
- Shouda, T. et al. (2001) J Clin Invest 108, 1781-8.
- Fang, M. et al. (2005) Cell Mol Immunol 2, 373-7.
- Goren, I. et al. (2006) J Invest Dermatol 126, 477-85.
- Mori, H. et al. (2004) Nat Med 10, 739-43.
- Howard, J.K. et al. (2004) Nat Med 10, 734-8.
Alternate Names
ATOD4; CIS-3; CIS3; Cish3; cytokine-induced SH2 protein 3; Cytokine-inducible SH2 protein 3; MGC71791; SOCS-3; SOCS3; SSI-3; SSI3; STAT-induced STAT inhibitor 3; Suppressor of cytokine signaling 3



风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验CST货号2923现货SOCS3 Antibody上海睿安生物19121878899
Source / Purification
Background
Low levels of SOCS3 are observed in lung, spleen and thymus, and like other SOCS family members levels its expression is rapidly induced by a number of factors including interleukins, EPO, IFN-γ, CSF and TNF-α (4). SOCS3 uses its SH2 domain to bind activated Jaks and their cognate receptors to provide negative feedback inhibition. In addition to the initially described inducers of SOCS3 expression, subsequent studies have described SOCS3-mediated negative feedback inhibition for leptin (5), GH (6), chemokine receptors (7), insulin (8) and certain pathogens (9,10). SOCS3 deletion results in embryonic lethality with placental insufficiency (11). SOCS3 signaling has been linked pathologically to allergic responses (12), inflammatory disease (13), endotoxic shock (14), wound repair (15), and obesity (16,17).
- Alexander, W.S. et al. (1999) J Leukoc Biol 66, 588-92.
- Chen, X.P. et al. (2000) Immunity 13, 287-90.
- Hilton, D.J. et al. (1998) Proc Natl Acad Sci USA 95, 114-9.
- Starr, R. et al. (1997) Nature 387, 917-21.
- Bjørbaek, C. et al. (1998) Mol Cell 1, 619-25.
- Adams, T.E. et al. (1998) J Biol Chem 273, 1285-7.
- Soriano, S.F. et al. (2002) J Exp Med 196, 311-21.
- Emanuelli, B. et al. (2000) J Biol Chem 275, 15985-91.
- Stoiber, D. et al. (1999) J Immunol 163, 2640-7.
- Stoiber, D. et al. (2001) J Immunol 166, 466-72.
- Roberts, A.W. et al. (2001) Proc Natl Acad Sci USA 98, 9324-9.
- Seki, Y. et al. (2003) Nat Med 9, 1047-54.
- Shouda, T. et al. (2001) J Clin Invest 108, 1781-8.
- Fang, M. et al. (2005) Cell Mol Immunol 2, 373-7.
- Goren, I. et al. (2006) J Invest Dermatol 126, 477-85.
- Mori, H. et al. (2004) Nat Med 10, 739-43.
- Howard, J.K. et al. (2004) Nat Med 10, 734-8.
Alternate Names
ATOD4; CIS-3; CIS3; Cish3; cytokine-induced SH2 protein 3; Cytokine-inducible SH2 protein 3; MGC71791; SOCS-3; SOCS3; SSI-3; SSI3; STAT-induced STAT inhibitor 3; Suppressor of cytokine signaling 3



Sci Adv:湘雅戴茹萍团队揭示 proBDNF 信号在系统性红斑狼疮中的作用
近日,中南大学湘雅二医院麻醉科戴茹萍教授团队在自然指数期刊、Science 子刊Science Advances(IF = 14.1)发表了题为 Upregulation of proBDNF/p75NTR signaling in antibody-secreting cells drives systemic lupus erythematosus 的原创研究,揭示了 proBDNF 在自身免疫性疾病系统性红斑狼疮(Systemic lupus erythematosus, SLE)中的
肿瘤标志物和信号通路的研究已经成为当前肿瘤研究的热点,但目前仍然缺少高效的研究工具。为此,上海华盈生物医药科技有限公司通过大量文献挖掘和潜心研制,开发出肿瘤标志物筛选抗体芯片和肿瘤信号通路磷酸化抗体芯片。产品于2013年9月第十六届全国临床肿瘤学大会上正式推出,为在肿瘤研究领域的科研工作者提供一种新的工具。 肿瘤标志物筛选抗体芯片&肿瘤信号通路磷酸化抗体芯片 肿瘤标志物筛选抗体芯片 (Cancer Biomarker Profiling
Western Blot 现在仍然是检测和分离蛋白最常用的一种实验方法,但是要想得到较好的结果并不容易,只有找到合适的实验条件并进行优化,才能以更少的时间得到更多的结果,达到事半功倍的效果!下面是 R&D Systems 品牌为您推荐的免疫印迹优化步骤和实验涉及参考数据:一抗浓度对实验结果的影响抗体:Human/Mouse/Rat RSK1 Antibody (Catalog # AF992)样本:人 HeLa 细胞 (Fig.1)A:5% 脱脂奶粉封闭,一抗浓度:1.0 mg/mL,溶于






